IBA GmbH - solutions for life sciences
IBA GmbH is dedicated to providing high quality product and service solutions for life science research in industry and academia.
The comprehensive portfolio ranges from nucleic acid custom services to products and services for cloning, transfection, recombinant protein production and cell isolation.
The combination of products and services allows IBA’s clients to choose either the proprietary products or, alternatively, the custom services, which are based on the same technologies, to get their research promoted.
“StarGate®” is a generic cloning system for rapidly identifying the optimal expression system for a given protein. After transfection with MATra, an efficient magnet assisted transfection technology using MagTag®, the Strep-tag®/Strep-Tactin® system is ideally suited for purification of highly pure and bioactive protein. Moreover, MHC-Streptamers are available for isolation and staining of functional T-cells. The complete detachability of the reagents leaves the cells indistinguishable from untreated cells. New Fab Streptamers allow the selection of eukaryotic cells which are characterized by specific surface markers. The complete reversibility of the reagents yields uncompromised, authentic cells for research, diagnostics and clinical use.
IBA’s nucleic acid unit provides individual and flexible custom services of nucleic acid specialties, including dsRNA as well as modified and fluorescently labeled oligos.
Dr. Lothar Germeroth
Chief Executive Officer
Lothar Germeroth studied chemistry in Frankfurt/Main and obtained his PhD in Biochemistry in the department of Nobel prize laureate Prof. Hartmut Michel at the Max-Planck Institute of Biophysics in Frankfurt. He started his professional carreer as group leader in a diagnostic company where he was responsible for the development of PCR-based HLA-dignostics and the quality control system of the company. Subsequently he served for eight years as CEO in three different German Biotech companies (Jerini BioTools GmbH, Chemotopix GmbH, Cytos Proteome Therapeutics GmbH) and as Chief Business Officer at Cytos biotechnology AG in Switzerland where he has closed several multimillion dollar deals with pharma industry. In April 2002, he joined IBA GmbH as CEO.
Dr. Thomas Schmidt
Chief Operating Officer
Thomas Schmidt studied biology in Munich and completed his studies with a Diplom thesis on antibody engineering in the laboratory of Prof. Plueckthun. After that he entered the department of Nobel prize laureate Prof. Michel at the Max-Planck Institute of Biophysics in Frankfurt, where he worked on his PhD thesis in the laboratory of Prof. Skerra. There he focused his research activities on molecular recognition and invented, together with Prof. Skerra, the Strep-tag technology for detection, purification, and assay of recombinant proteins. In July 1994, he was appointed by IBA, where he further developed this technology, transformed it into successful products, and managed their commercialization.
Dr. Joachim Bertram
Chief Scientific Officer
Joachim Bertram received his Ph.D. in microbiology in the department of Prof. Gottschalk at the University of Goettingen. Then he moved to the department of hematology and oncology headed by Prof. Hiddemann where he has held a number of positions of increasing seniority in the biomedical profession. He conducted scientific and applied research on the use of antisense oligonucleotides and ribozymes in the field of proliferative diseases. In addition he focussed on mechanisms of drug resistance development and the use of nucleic acid based compounds for growth factor mimicry. In 1998, Joachim Bertram finished his "habilitation" in the medical faculty. He joined IBA GmbH in January 2000 and became CEO of IBA Biologics in 2001.
Dr. Herbert Stadler
Head of the Advisory Board
Over the last two decades, Herbert Stadler has built a track record as one of Germany's most active biotech entrepreneurs. He has founded or co founded several companies including Biometra GmbH, Ribonetics GmbH, HepaVec AG, IBA GmbH and DeveloGen AG. Herbert Stadler is a neurochemist by training. He obtained his Ph.D. at the Freie University of Berlin, obtained his postdoctoral lecture qualification ("Habilitation") at the University of Göttingen and headed the Molecular Neurobiology Group at the Max-Planck Institute of Biophysical Chemistry in Göttingen. He currently serves on the supervisory boards of DeveloGen AG and IBA GmbH.
Dipl. Biol. Bettina Renker, MSc, Product Manager "Transfection and Nucleic acids"
Dr. Gisela Mäck, Product Manager "Cell TAGnologies"
Dr. Isabel Schuchardt, Product Manager "Cloning/Expression/Purification"
Dr. Uwe D. Carl
General contact information
Phone +49 (0) 551 50672-0
Fax +49 (0) 551 50672-181
Gold medal at BIOMOD 2014
At the BIOMOD 2014 competition, Wyss Institute in Harvard, students from the group of Prof. Dr. Tinnefeld, TU Braunschweig, Germany, won a gold medal for the “Nanoscooter”, a nanoscale car consisting of DNA. Also for their suit the won the prize for the best T-shirt. BIOMOD is an annual biomolecular design competition for students. See also http://openwetware.org/wiki/Biomod/2014/Braunschweig.
Sponsored by IBA.
IBA GmbH has established “Young Scientist Sponsorships” for attending retreats, meetings or conferences.
- Dr. Thomas Lavergne, CNRS GRENOBLE, France. 1st "Gänse-Liesel" conference fee for young scientists for speakers of the 16th Symposium on Chemistry of Nucleic Acid Components (16. SCNAC) in the Czech Republic
- Dr. Michael Schmück, Charité - Universitätsmedizin Berlin, Germany. Conference fee for the ISCT 2014 Annual Meeting in Paris, France
- Students´ Retreat of the Harvard Virology Program, Harvard Medical School, Boston, USA